You have requested access to member only content.
Four years after fungal meningitis outbreak, compound pharmacy safety concerns linger
In 2012, a fungal meningitis outbreak was linked to the New England Compounding Center (NECC) in Framingham, Massachusetts, that would eventually lead to more than 750 infections in 20 states and 64 deaths, according to the CDC.
The publicized outbreak thrust compounded medicine into the public eye, prompting many facilities and states to review oversight of quality and safety.
But four years later--and three years after the federal government finalized a law that placed tighter restrictions on the compounding industry--state oversight varies considerably and safety concerns still linger among compounded medications.
This is an excerpt from members-only content. Please log in or become a member to access the full content.
Please Log In
Unable to log in?
Click here to reset your password or unlock your account.
Forgot your username?
Contact customer care at customerservice@hcpro.com or call 800-650-6787, between 8 AM - 5 PM CT
Not a member? Let's fix that!
A membership to Accreditation and Quality Compliance Center provides accreditation and safety professionals with a collection of continuously updated tools, best-practice strategies, and compliance tips developed by industry experts. With two membership options, you can customize your access level depending on your education and training needs.
Register to access the free content available on the site or become a member today. Click here for more information.
For questions and support, please call customer service: 800-650-6787.